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Background: Brachycephalic dogs have abnormal breathing patterns similar to those in humans 
with obstructive sleep apnea syndrome (OSAS). Obstructive sleep apnea syndrome is associated 
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with dyslipidemia, hyperglycemia and insulin resistance. Despite the fact that anatomic and 
functional alterations are well described in brachycephalic dogs, little is known about the 
consequences of upper airway obstruction on systemic inflammatory response and metabolic 
profile. 
Objectives: To describe history, clinical presentation and anatomic abnormalities; to evaluate 
systemic inflammatory response and metabolic profile; and to identify possible associations 
among clinical signs, anatomic abnormalities, inflammatory response and metabolic profile  
Animals: Thirty purebred brachycephalic dogs with brachycephalic airway obstructive syndrome 
(BAOS). 
Methods: Prospective study. The following information was recorded and studied: 
respiratory/digestive signs, airway/digestive endoscopic anomalies, presence/absence of tracheal 
hypoplasia, histologic evaluation of gastrointestinal tract biopsy specimens, serum 
concentrations of C-reactive protein (CRP), fructosamine, insulin, glucose, triglyceride, 
cholesterol and plasma concentrations of lipoprotein classes. 
Results: A high proportion of dogs (76.7%) had gastrointestinal signs. Esophageal deviation, 
atony of the cardia of the stomach and distal esophagitis were the most common endoscopic 
anomalies detected. Twenty-six (86.6%) dogs had different degree of laryngeal collapse. 
Gastrointestinal histologic evaluation identified mostly chronic inflammation. Glucose, 
fructosamine, triglycerides, cholesterol, CRP, pre-beta, beta lipoproteins and chylomicrons were 
increased to a variable extent. Significant associations among clinical signs, anatomic 
abnormalities, CRP and metabolic profile were not found. 
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Conclusion and clinical importance: Despite the presence of inflammation and some mild 
metabolic derangements, the clinicopathological variables evaluated did not offer valuable 
information in dogs with BAOS.  
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Introduction 
Brachycephaly, or a shortened facial structure, is a common condition of dogs that is magnified by selective breeding. Breeds most 
commonly affected by brachycephalic airway obstructive syndrome (BAOS) are English and French bulldogs, Pugs and Boston 
terriers.
1
 Most dogs with this condition develop BAOS, a chronic upper airway obstruction clinically characterized by heat stress and 
exercise intolerance, snoring, inspiratory dyspnea, cyanosis and, in more severe cases syncopal episodes.
2
 In addition, gastrointestinal 
signs such as dysphagia, vomiting and regurgitation can develop as a consequence of the negative intrathoracic pressure generated by 
increased respiratory effort and aerophagia, and worsen upper esophageal, pharyngeal and laryngeal inflammation.
2-4
 Excessive 
flatulence as a consequence of aerophagia also is often present. French bulldogs often have more frequent and severe digestive signs 
than do pugs.
4-7 
Because medical management may only temporarily improve clinical signs and provide palliation, permitting progression of the 
disease to a more advanced stage,
8
 surgical treatment consisting of rhinoplasty, turbinectomy, staphylectomy, laryngeal sacculectomy 
or some combination of these often is required.
9,10
 Brachycephalic airway obstructive syndrome shares features of obstructive sleep 
apnea (OSA) in people, a form of sleep-disordered breathing characterized by recurrent collapse of the upper airway during sleep 
leading to intermittent hypoxia, oxygen desaturation, sleep fragmentation and arousal from sleep.
11,12
 Obstructive sleep apnea is 
prevalent in obese individuals,
13
 and is associated with decreased survival as a result of development of cardiovascular and 
thromboembolic disorders.
11,14
 Moreover, growing epidemiological evidence suggests that OSA is linked to metabolic abnormalities, 
such as hyperglycemia, insulin resistance, type 2 diabetes and dyslipidemia.
15,16 
Although spontaneous OSA is very uncommon in 
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animals, the English bulldog has been used as an animal model of OSA because of its disordered breathing and episodes of oxygen 
desaturation associated with abnormal upper airway anatomy.
17,18
 Despite the fact that anatomic and functional alterations are well 
described in brachycephalic dogs,
1-9, 18-22
 little is known about the consequences of upper airway obstruction on the systemic 
inflammatory response, parameters of glucose regulation,  and lipid metabolism.
22-24
 Thus, our prospective study was designed to: 1) 
describe history, clinical presentation and anatomic abnormalities; 2) evaluate the systemic inflammatory response, parameters of 
glucose regulation, and lipid profiles; and, 3) identify possible associations among clinical signs, anatomic abnormalities, 
inflammatory response, parameters of glucose regulation and lipid profiles in a series of brachycephalic dogs with BAOS. 
Materials and Methods 
Purebred brachycephalic dogs with BAOS presented to different veterinary teaching hospitals and referral clinics over a 2-year period 
were included in the study. At admission, each dog’s case history was obtained from the owner. The frequency and nature of upper 
respiratory (e.g., snoring, inspiratory efforts, stress or exercise intolerance, syncope) and digestive (e.g., ptyalism, regurgitation, 
vomiting) signs were assessed according to a previously described grading system.
25 
The frequency
 
of both respiratory and digestive 
signs was classified as follows: never, occasionally (less than once monthly), regularly (once weekly), daily (once daily), often (more 
than once daily), and constantly. Inclusion of at least 1 sign in a higher grade determined the classification assigned. On the basis of 
the frequency of each respiratory sign, a global classification of 3 grades was assigned: grade 1 (absent or minimal), grade 2 
(moderate), grade 3 (severe). The same was done for the frequency of each digestive sign.
25
 For each dog, a final symptomatic score 
from the global classifications of both upper respiratory and digestive signs was obtained. In addition to upper respiratory and 
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digestive signs, sleep-disordered breathing (SDB) history (e.g., night time arousals, respiratory signs and attitude after arousals, 
owner’s perception that sleep disruption was caused by airway obstruction, abnormal sleeping positions) was collected for each dog. 
The information about abnormal sleeping positions was retrospectively gleaned by telephone interview at the time of the manuscript 
drafting. Dogs were classified according to the presence (score 1) or absence (score 0) of at least 1 clinical sign or abnormal attitude 
during sleep. The frequency of night time arousals was classified arbitrarily as follows: never (score 0), mild (1 to 3 times per night; 
score 1), moderate to severe (≥ 4 times per night; score 2). A clinical examination was performed, body weight was recorded and a 9-
point body condition score (BCS) was assigned.
26
 Physical examination and cardiac auscultation findings, echocardiographic and 
radiographic abnormalities, and blood test results provided evidence that no other clinically relevant diseases were present in dogs 
included in the study. 
Aliquots of serum and plasma obtained from centrifugation of blood collected from each dog for pre-anesthetic investigations were 
separated and immediately stored at -20°C for biomarker analysis. Sample storage varied from 1 to 5 days. Biomarker analyses were 
performed in 2 different laboratories (BiEsseA s.r.l. Milan, Italy;
a
 Ematos Vet Lab s.r.l. Rome, Italy
b
) and included evaluation of 
serum concentrations of fructosamine,
a
 insulin,
a
 glucose,
a
 total protein,
b
 C-reactive protein (CRP),
b
 triglycerides
b
 and cholesterol.
b
 In 
addition, plasma lipoprotein agarose gel electrophoresis (Hydrasis, Sebia, UK ltd)
b
 was performed using a dedicated kit
 
(Hydragel 
protein, Sebia, UK ltd).  
Upon signed owner consent for diagnostic and therapeutic procedures, all dogs underwent pre-surgical endoscopic evaluation of the 
airways (nares, rhino- and oro-pharynx, larynx, trachea and bronchi) and, if digestive signs were present, the esophagus, stomach and 
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duodenum. Premedication protocols were decided on a case-by-case basis (.2 mg/kg methadone alone or in combination with 10 µg/kg 
acepromazine). Pre-oxygenation was provided for 5 minutes before endoscopy using a face-mask. General anesthesia was induced 
with 2-4 mg/kg propofol IV and maintained by gas anesthesia (isoflurane or sevoflurane in 100% oxygen). Intravenous 
methylprednisolone sodium succinate (1 mg/kg) was given to control laryngeal edema at anesthesia induction. All endoscopic 
procedures were performed in standardized fashion by 3 of the authors (C.R., B.E., P.M.).
27-29 
In the event of gastrointestinal 
endoscopic evaluation, mucosal biopsy samples were collected and submitted for histologic evaluation. Rigid (2.7 mm × 18 cm, 30°; 
model 64029, Karl Storz Endoscopia Italia S.r.l., Verona - Italy) and flexible (6.0 mm × 103 cm; EG-1840, Pentax Italia S.r.l., Milano, 
Italy; 7.8 mm × 140 cm, model PV-SG 28-140, Karl Storz Endoscopia Italia S.r.l., Verona, Italy; 5.0 mm × 55 cm fiberscope; 
Olympus BF-P40, Olympus Medical Systems Europe GmbH, Hamburg, Germany) video endoscopes were used. Images and movies 
were acquired using video recording devices (Pinnacle Studio 21.5; Corel Corporation, Ottawa, Canada; Tele Pack Vet X Led, Karl 
Storz Endoscopia Italia S.r.l.).  
Balanced isotonic crystalloid fluids were administered IV to all dogs during the entire procedure; ECG, blood pressure, and pulse 
oximetry were monitored continuously. During recovery, supplemental oxygen was provided as needed. The definitive diagnosis of 
BAOS was made by combining both upper airway respiratory signs and anatomic abnormalities, as has been described elsewhere.
30
 
Laryngeal paralysis (unilateral or bilateral) was defined as a total lack of abduction of the corniculate processes of the arytenoids 
during inspiration. 
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To describe anatomic abnormalities, a quantitative anatomical scoring system was used by evaluating the following variables recorded 
at presentation and at the time of radiography and endoscopy: tracheal hypoplasia (tracheal diameter to the thoracic inlet ratio < 
0.16),
31
 tracheal collapse, bronchial collapse, turbinate hypertrophy, stenotic nares, macroglossia or elongated tongue, elongated soft 
palate, thickened soft palate, nasopharyngeal collapse, altered rhynopharyngeal mucosa (hypertrophy, erosions, erythema), increased 
laryngopharyngeal secretions, laryngopharyngeal erosions, laryngopharyngeal nodules, and hypertrophy and eversion of the tonsils. 
Each variable was classified as present (score 1) or absent (score 0). A final quantitative anatomical score was obtained by the sum of 
each single score. In addition, the extent of laryngeal collapse was assessed endoscopically as mild (eversion of laryngeal saccules, 
first degree, score 1), moderate (medial displacement or overlap of the cuneiform processes, second degree, score 2) or severe (medial 
displacement or overlap of the corniculate processes, third degree, score 3), based on a previous classification.
32
  
Statistical Analysis 
Preliminarily, the symptomatic score was dichotomized on the basis of the median value (≤4 vs ≥5) and a 2-stage analysis was 
applied. In the first stage, all of the variables were tested using the χ2 test. Quantitative data were divided arbitrarily into 2 categories 
based on the medians of values. The proportion of dogs with symptomatic score ≥5 was evaluated by breed, sex, BCS, body weight, 
age, mean arterial pressure (MAP, mm/Hg), percent saturation of oxygen (SpO2), SDB history (i.e., night time arousals, respiratory 
signs and attitude after arousals, owner’s perception that sleep disruption was caused by airway obstruction, abnormal sleeping 
positions, presence of at least 1 clinical sign or abnormal attitude during sleep regardless of the type of clinical sign or abnormal 
attitude), quantitative anatomical score, laryngeal collapse score, serum concentrations of cholesterol (mg/dL), triglycerides (mg/dL), 
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total protein (g/dL), glucose (mg/dL), insulin (µU/ml), CRP (mg/dL),  and fructosamine (μmol/L), and plasma pre-alpha (%), alpha 1 
(%), alpha 2 (%), pre-beta (%), beta (%), and chylomicrons  (%) lipoprotein classes. 
In the second stage, factors that had P values < .20 then were evaluated using binary logistic regression. The model was based on the 
simultaneous entry of all variables, and its efficacy was assessed based on the likelihood ratio and the Hosmer-Lemeshow statistic. 
Values of P < .05 were considered significant. The odds ratio (OR) and 95% confidence intervals (95% CI) were calculated from the 
final binary logistic model.  
All statistical analyses were performed using statistical software (IBM SPSS 25.0.0, Armonk, NY, USA). 
Results 
Signalment, clinical signs and laboratory data 
Thirty dogs affected by BAOS were included in the study, subdivided as follow: 10 Pugs (33.3%), 13 French Bulldogs (43.3%) and 7 
English Bulldogs (23.3%). Twenty-two dogs were intact males and 8 were females (4 spayed). The median age was 36.4 months 
(range, 10-93). The median body weight was 13.4 kg (range, 6-34). The median BCS was 6.6 (range, 5-8). The most common 
presenting respiratory clinical signs were snoring (28 dogs, 93.3%), increased inspiratory efforts (28 dogs, 93.3%) and stress or 
exercise intolerance (28 dogs, 93.3%), and syncope (7 dogs, 23.3%). Among the dogs with snoring, 16 (57.1%) snored constantly, 
whereas 12 (42.9%) snored with a frequency equal to or more than once daily. Among the dogs with increased inspiratory efforts, 12 
(42.9%) were affected constantly, 12 (42.9%) with a frequency equal to or more than once daily, 2 (7.1%) regularly, and 2 (7.1%) 
occasionally. Among the dogs with stress or exercise intolerance, 5 (17.9%) had it constantly, 19 (67.9%) with a frequency equal to or 
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more than once daily, 1 (3.6%) regularly, and 3 (10.7%) occasionally. Among the dogs with syncope, 4 (66.7%) fainted regularly, and 
3 (42.6%) occasionally. For 1 dog, the frequency of respiratory signs could not be precisely defined. Twenty-three (76.7%) dogs had 
gastrointestinal clinical signs in addition to respiratory clinical signs. Nineteen (76%) dogs had vomiting, 2 (10.5%) with a frequency 
equal to or more than once daily, 8 (42.1%) regularly, and 9 (47.4%) occasionally. Fourteen dogs (60.9%) had regurgitation, 1 (7.1%) 
of which regurgitated constantly, 3 (21.4%) with a frequency more than once daily, 3 (21.4%) regularly, and 7 (50%) occasionally. 
Eleven (47.8%) dogs had ptyalism, 1 (9.1%) of which at a frequency of once daily, 5 (45.4%) regularly, and 5 (45.4%) occasionally. 
Twenty (66.7%) dogs experienced night time arousals, with mild and moderate to severe frequency in 12 (60%) and 8 (40%) dogs, 
respectively. For 17 (85%) dogs, the owner’s perception was that disruption of sleep was caused by the airway obstruction. Three 
(15%) dogs had coughing bouts after arousal, 3 (15%) panting and pacing at night, 2 (10%) loud snoring, apnea followed by abrupt 
arousal and reverse sneezing, and 1 (5%) reverse sneezing. Two (10%) dogs assumed abnormal sleeping positions with elevated chin. 
Signalment, respiratory and digestive clinical signs and SDB history can be found in supplementary information. Tables 1 and 2 show 
laboratory data. Results of the univariate and logistic regression analysis are found in Tables 3 and 4, respectively. 
Odds ratio of symptomatic score ≥5 was not significantly associated with the factors evaluated. 
Evaluation of airway anatomic abnormalities and quantitative scoring system 
Twenty-nine dogs underwent airway endoscopic evaluation. In 1 dog, because of clinical sign severity, endoscopic evaluation was not 
completed, and was followed by tracheal stent placement and surgical correction of BAOS. Twenty-nine (100%) dogs had stenotic 
nares and elongated soft palate, 21 (72.4%) turbinate hyperthrophy, 19 (65.5%) macroglossia, 17 (58.6%) increased 
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laryngopharyngeal secretions, 16 (55.2%) thickened soft palate, 13 (44.8%) nasopharyngeal collapse, 11 (37.9%) hypertrophy and 
eversion of the tonsils, 8 (27.6%) altered rhynopharyngeal mucosa, 6 (20.7%) laryngopharyngeal nodules, and 4 (13.8%) tracheal 
collapse, tracheal hypoplasia and bronchial collapse. Laryngopharyngeal erosions were not observed. Normal laryngeal function was 
observed in all dogs. Twenty-six (86.6%) dogs had laryngeal collapse, which was evaluated as grade 3, 2 and 1 in 2 (7.7%), 15 
(57.7%) and 9 (34.6%) dogs, respectively. The remaining 3 dogs had a larynx without any degree of collapse. The median final 
quantitative anatomical score was 6 (range, 4-9). Results of univariate analysis of quantitative anatomical score, SDB history and 
laryngeal collapse score showed no statistically significant differences (P > .05, Table 3). 
Digestive endoscopic anomalies and histological evaluation 
Gastroduodenal endoscopy was performed in 21 (91.3%) of 23 dogs that had gastrointestinal clinical signs in addition to respiratory 
clinical signs. In the remaining 2 dogs, gastroduodenal endoscopy was not performed because of lack of owner consent.  
Overall, all 21 dogs had ≥ 1 endoscopic esophageal, gastric or duodenal anomalies. Esophageal deviation, atony of the cardia of the 
stomach, distal esophagitis and precardial erosions were observed in 9 (42.9 %), 3 (14.3 %), 7 (33.3 %) and 2 (9.5 %) of cases, 
respectively. Gastric stasis, pyloric mucosal hyperplasia, duodenogastric reflux, diffuse erythema, punctiform inflammation, erosions 
and edema were observed in 6 (28.6 %), 4 (19 %), 1 (4.8 %), 7 (33.3 %), 3 (14.3 %), 1 (4.8 %) and 10 (47.6 %) dogs, respectively. 
Diffuse duodenal erythema, edema, mucosal irregularity and whitish tips of swollen villi were observed in 16 (76.2 %), 2 (9.5 %), 9 
(42.9 %) and 2 (9.5 %) dogs, respectively.  
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Mucosal biopsy samples were collected from all dogs undergoing gastroduodenal endoscopy and submitted for histologic evaluation. 
Histologic examination was performed in all dogs according to a quantitative simplified scoring system.
33
  
Lymphocytic-plasmacytic inflammation and squamous metaplasia of the esophagus were found in 1 (4.8%) and 1 (4.8%) dogs, 
respectively. Lymphocytic-plasmacytic inflammation, erosions with neutrophilic inflammation, fibrosis and mucosal hyperplasia of 
the stomach were found in 12 (57.1%), 2 (9.5%), 2 (9.5%) and 1 (4.8%) dogs, respectively. Lymphocytic-plasmacytic inflammation, 
neutrophilic inflammation, lacteal dilatation and epithelial injury of the duodenum were found in 10 (47.6%), 7 (33.3%), 9 (42.9%) 
and 1 (4.8%) dogs, respectively. 
The anatomical lesions observed can be found in the supplementary information. 
Discussion 
Our study provides a systematic description of the clinical presentation, as well as clinicopathological and airway anatomic 
abnormalities in a population of brachycephalic dogs with BAOS, and explores their possible association with systemic inflammatory 
response, parameters of glucose regulation and lipid profiles. 
Obstructive sleep apnea describes recurrent collapse of the upper airway during sleep leading to intermittent hypoxia (IH).
11
 Growing 
evidence from animal models of OSA suggests that IH is independently associated with metabolic dysfunction, including dyslipidemia 
and insulin resistance.
34
  
The precise mechanisms by which IH induces metabolic disturbances are not fully understood. Dyslipidemia may be caused by 
excessive lipolysis supplying free fatty acids to the liver, up-regulation of hepatic triglyceride biosynthesis and lipoprotein secretion 
14 
 
and suppression of lipoprotein clearance.
35
 Insulin resistance may be caused by activation of hepatic lipid biosynthesis, activation of 
the sympathetic nervous system with consequent lipolysis, the hypothalamic-pituitary-adrenal axis and systemic inflammation.
34,36 
Although BAOS in brachycephalic dogs is not identical to OSA in humans, important similarities exist and, because English Bulldogs 
have been used as a spontaneous animal model for human OSA, it would be reasonable to presume that other brachycephalic dogs 
may similarly be at risk for IH. 
Within the study population, median age was 3 years, median BCS was 6.6 and male dogs were more common than female dogs, 
consistent with available literature data.
22-24,48
 In humans, obesity is a major risk factor for OSA and the effect of BCS has been 
reported as a potential aggravating factor for brachycephalic syndrome, although no correlation between BCS and the severity of 
upper airway obstruction has been found, as in our study.
8,39,40
 In human medicine, waist circumference, neck circumference and 
deposition of fat around specific parts of the body are considered in addition to the use of body mass index.
41,42
 On the contrary, in 
veterinary medicine, with the exception of neck girth evaluation,
43,44
 obesity is defined based on BCS. Therefore, additional studies 
considering other obesity-related parameters are needed to explore a possible correlation with increased BAOS risk, as recently found 
for neck girth ratio in male bulldogs.
44
 
Consistent with available data, snoring, inspiratory efforts and exercise intolerance were the most common presenting clinical signs, 
followed by syncope.
5,25 
Moreover, 76.7% of dogs with respiratory problems also had gastrointestinal clinical signs, specially 
vomiting and regurgitation.
7,22,25,45,46
 Although it is not frequently described, SDB may be consequence of BAOS.
17,48
 Indeed, sleep is 
thought to exacerbate BAOS because the muscles that dilate the upper airways relax.
2
 Sleep-disordered breathing has been described 
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in Pugs, French Bulldogs, English Bulldogs and, more recently, in Cavalier King Charles Spaniels.
17,30,49
 In our study, more than half 
of the dogs showed clinical signs of SDB. However, without polysomnography and follow-up information, it is not possible to better 
characterize SDB and conclude that BAOS at least contributed to sleep apnea.
17,50
 With regard to the airway anatomic abnormalities, 
our findings were consistent with those of other studies, but a higher number of dogs showed laryngeal collapse (86.6%).
9,25,45
 
Tracheal and bronchial collapse were detected only in a minority of dogs (13.8%). These results are not surprising because laryngeal 
collapse is considered a common secondary functional change occurring in brachycephalic dogs, along with pharyngeal and tonsillar 
hyperplasia and bronchial collapse.
47,51,52
 However, the severity of respiratory and digestive clinical signs seen at presentation and at 
the time of radiography and endoscopy was not influenced by the number of anatomic abnormalities or severity of laryngeal collapse, 
whereas a correlation between laryngeal collapse and bronchial abnormalities has already been described elsewhere.
52 
This lack of 
relationship, however, could be explained by the presence of other anomalies that are not routinely evaluated, such as obstructing 
turbinates, deviation of the nasal septum or narrowing or distortion of the retropharyngeal space, in addition to a different combination 
of anatomic abnormalities and breed-specific anatomical airway differences.
53-55
   
As reported elsewhere, esophageal deviation, distal esophagitis, atony of the cardia of the stomach, gastric stasis, pyloric mucosal 
hyperplasia, and gastrointestinal inflammation were the most common endoscopic anomalies recorded, although esophageal deviation 
and pyloric mucosal hyperplasia were observed more and less frequently, respectively.
25 
Gastro-esophageal reflux and hiatal hernia 
were not identified. However, considering that sliding hiatal hernia is by far the most frequently observed in dogs and its frequency is 
underestimated by radiography or endoscopy,
 
it cannot be definitively excluded here. In addition, hiatal hernia may not have been 
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diagnosed because of the effects of tracheal intubation and anesthesia.
4,7
 Finally, the gastrointestinal tract of dogs without digestive 
signs was not evaluated, although brachycephalic dogs may have mild digestive anomalies and inflammation even without having 
digestive signs.
25
  
Consistent with available data, histologic evaluation of the stomach and duodenum identified mostly chronic inflammation,
25,45
 in 
addition to lacteal dilatation, not previously reported. Because brachycephalic breeds are not overrepresented among dogs with 
intestinal lymphangiectasia, it can be hypothesized that the lacteal dilatation could have been a consequence of chronic gastrointestinal 
inflammation, rather than a primary gastrointestinal problem.
56
 However, it cannot be determined because a specific diagnostic 
evaluation of intestinal signs was not undertaken. To our knowledge, ours is the first prospective clinical study of dogs wiht BAOS 
that has evaluated parameters of glucose regulation and lipid profiles and their relationship with clinical signs and anatomical 
abnormalities. Glucose, fructosamine, total cholesterol and triglyceride concentrations were increased in variable proportions in dogs 
in our study. In human medicine, an association between OSAS and insulin resistance was observed in some studies, whereas it was 
not clear in others.
57
 Moreover, SDB can be the cause of notable glycemic variability, which in turn is associated with complications 
of diabetes.
58 
However, no relationship between increased blood glucose concentrations and severity of OSAS was detected in non-
diabetic patients, as in dogs with BAOS described here.
59
 Increased fructosamine concentrations were observed in almost one-third 
(32.1%) of the dogs, whereas hyperglycemia was only found in a smaller proportion (14%). Because hyperproteinemia as a possible 
cause of increased fructosamine concentrations was ruled out, this discrepancy might be explained by the presence of intermittent 
hyperglycemia, perhaps related to surges in sympathetic activity secondary to respiratory distress.
34,36
 None of the dogs in our study 
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had hyperinsulinemia, whereas decreased serum insulin concentrations were observed in almost all dogs (92.6%). Because no 
evidence of any other diseases was found in dogs included in the study, lower than normal serum insulin concentrations were 
considered to be caused by pre-anesthesia fasting. The majority of studies in human medicine suggests that triglyceride but not total 
cholesterol concentrations are increased in OSAS patients, and that continuous airway pressure has a positive effect on lowering the 
serum concentrations of both analytes.
60,61
 Total cholesterol and triglyceride concentrations were normal in approximately 70% of the 
dogs studied here, whereas lipoprotein classes were increased in the majority of the dogs, perhaps suggesting that serum lipoprotein 
electrophoresis is more accurate in detecting dyslipidemia in dogs than are total cholesterol and triglyceride concentrations.
62
 In 
veterinary medicine, a gold standard validated method for the evaluation of canine lipoproteins is currently lacking, and many 
published reports have utilized automated electrophoretic protocols developed for human use, as in our study.
63-65
 However, the 
electrophoresis method used here was selected because some studies have documented that it might be more accurate than the wet 
chemistry method for identifying some lipoprotein classes, especially low-density lipoproteins, which are substantial in dogs.
63,66
 The 
alpha fraction is the sum of the pre-alpha, alpha-1 and alpha-2 components and is predominant in normal dogs, and the canine high-
density lipoproteins (HDL) seem to show this migratory pattern.
67,68 
In veterinary medicine, to date, a decrease in low-density 
lipoproteins (LDL) was reported in chronic kidney disease, nephrotic syndrome and pancreatitis in dogs.
67,69,70
 In our study, these 
lipoprotein classes were normal in the majority of the dogs (80%) whereas the pre-beta and beta classes, corresponding to the very low 
density lipoproteins (VLDL) and LDL, respectively, and the chylomicrons, were increased in more than half of the dogs.
68 
In 
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veterinary medicine, to date, both classes are increased in chronic kidney disease, nephrotic syndrome, diabetes mellitus and 
pancreatitis.
66,69-71
  
Limited information exists in dogs with BAOS with regard to the systemic inflammatory response. C-reactive protein concentration 
was found to be increased in 14% of dogs, but no statistical correlation was found with severity of clinical signs or after surgery.
22,24
 
In another study, some proinflammatory cytokines and nitric oxide were found to be higher in brachycephalic dogs than control dogs 
and to be associated with disease severity.
23
 In our study, half of the dogs showed increased CRP concentrations, suggesting that a 
systemic inflammatory response might be common in dogs with BAOS.  
Our study failed to identify a significant association between severity of clinical signs and anatomic abnormalities, inflammatory 
response, parameters of glucose regulation and lipid profiles.  
Our study had some limitations, primarily related to relatively small sample size, considering the different degrees of BAOS severity 
addressed. Other limitations were that the quantitative scoring system was assessed by a single observer at each center and therefore 
was somewhat subjective, gastroduodenal endoscopy was only performed in dogs with gastrointestinal signs, and polysomnography 
and exercise testing were not performed to better characterize SDB and improve BAOS’s assessment.50,72 Moreover, it was not 
possible to include a control group in our study because of the difficulty in findings brachycephalic dogs with normal breathing 
pattern. Nearly all brachycephalic dogs have some degree of upper airway obstruction.
2,72
 Lastly, information about the gold standard 
method for lipoprotein evaluation as well as the pathophysiology of their metabolism in dogs is lacking. Without this information, the 
clinical utility of some data presented here is unknown and cannot be interpreted reliably. 
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In conclusion, it seems that the clinicopathological variables considered do not offer valuable information in dogs with BAOS. On the 
other hand, however, the presence of an inflammatory response and some mild metabolic derangements suggest the need to further 
explore the metabolic profile and inflammatory status of dogs with BAOS using studies including more animals with similar degrees 
of BAOS severity.  
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 Table 1. Cholesterol, triglyceride, glucose, total protein, fructosamine, insulin and C-reactive protein serum concentration results  
Variables Median values (range) Mean values (±SD) Normal values 
% 
(n/t) 
Values above the R.R. % 
(n/t) 
Values below the 
R.R. % 
(n/t) 
Cholesterol 210.5 mg/dL (101-373) 221.8 mg/dL (±68.3) 73.4% (22/30) 20% (6/30) 6.6% (2/30) 
Triglyceride 88.5 mg/dL (29-208) 101.2 mg/dL (±50.0) 67.9% (19/28) 32.1% (9/28) - 
Glucose 100.5 mg/dL (72-227) 102.6 mg/dL (±27.8) 85.7% (24/28) 14.3% (4/28) - 
Total Protein 5.6 g/dL (4.5-7.3) 5.7 g/dL (±0.8) 65.5% (19/29) - 34.5% (10/29) 
Fructosamine 237 µmol/L (100-329) 241.5 µmol/L (±52.1) 64.3% (18/28) 32.1% (9/28) 3.6% (1/28) 
Insulin 1.9 µU/ml (1.9-10.8) 2.5 (±2.0) 7.4% (2/27) - 92.6% (25/27) 
C-reactive protein 0.6 mg/dL (0.0-19.10.10) 1.7 mg/dL (±3.8) 48.1% (13/27) 51.9% (14/27) - 
 
n=number of dogs in which the variable was normal, above or below the reference range 
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t=total number of dogs 
R.R.= reference range 
SD=standard deviation 
 
Table 2. Plasma lipoprotein electrophoresis results  
Lipoprotein classes (R.R.) Median values (range) Mean values (±SD) Normal values % 
(n/t) 
Values above the R.R. % 
(n/t) 
Values below the R.R. % 
(n/t) 
Prealfa (pα) (.8-2.5%) 1.8% (0.9-9.1) 2.3% (±1.8) 80% (16/20) 20% (4/20) - 
Alfa 1 (α1) (30.9-40.6%) 32.6% (25.6-43) 32.7% (±3.7) 75% (15/20) 5% (1/20) 20% (4/20) 
Alfa 2 (α2) (21.5-35.0%) 25.2% (17.5-33.6) 25.8 (±4.5) 85% (17/20) - 15% (3/20) 
Prebeta (pβ) (4.9-11.0%) 12.9% (5.4-23.6) 13.8 (±5.9) 40% (8/20) 60% (12/20) - 
Beta (β) (11.1-19.0) 19.7% (10.8-26.0) 18.7 (±4.7) 40% (8/20) 55% (11/20) 5% (1/20) 
Chylomicrons (κ) (1.3-3.4) 5.7% (1.6-16.2) 6.7 (±4.1) 35% (7/20) 65% (13/20) - 
 
R.R.= reference range 
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n=number of dogs in which the lipoprotein class was normal, above or below the reference range 
t=total number of dogs 
SD=standard deviation 
 
Table 3. Results of univariate analysis 
  Symptomatic score   
Variables  score≤4 score≥5 Total P 
Breed French bulldog s 6 7 13 .75 
 English bulldogs 2 5 7  
 Pugs 4 6 10  
Sex Male 8 14 22 .68 
 Female 4 4 8  
BCS ≤ 6 7 6 13 .26 
 > 6 5 12 17  
Body weight (kg) ≤ 11.7 7 8 15 .71 
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 > 11.7 5 10 15  
Age (months) ≤ 36 6 12 18 .46 
 > 36 6 6 12  
MAP (mm/Hg) ≤ 70 7 3 10 .05a 
 > 70 5 15 20  
SpO2 ≤ 98 7 4 11 .06
 a
 
 > 98 5 14 19  
Quantitative anatomical score ≤ 6 8 9 17 .47 
 > 6 4 9 13  
Night time arousal never 5 5 10 .72 
 mild 4 8 12  
 moderate/severe 3 5 8  
Respiratory signs and attitude after arousals present 10 11 11 .25 
 absent 2 7 9  
Owner’s perception that sleep disruption was 
caused by airway obstruction 
present 7 6 13 .26 
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 absent 5 12 17  
Abnormal sleeping positions present 12 16 28 .50 
 absent 0 2 2  
Presence of at least 1 clinical sign or abnormal 
attitude during sleep 
yes 5 5 10 .46 
 no 7 13 20  
Laryngeal collapse score ≤ 2 5 7 12 1 
 > 2 7 10 17  
Cholesterol (mg/dL) ≤ 210.5 8 7 15 .26 
 > 210.5 4 11 15  
Triglyceride (mg/dL) ≤ 88.5 8 7 15 .26 
 > 88.5 4 11 15  
Total protein (g/dL) ≤ 5.6 5 10 15 .71 
 > 5.6 7 8 15  
Glucose (mg/dL) ≤ 100.5 6 8 14 1 
 > 100.5 6 10 16  
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C-reactive protein (mg/dL) ≤ .55 7 7 14 .46 
 > .55 5 11 16  
Fructosamine (umol/L) ≤ 237 6 8 14 1 
 > 237 6 10 16  
Insulin (µU/ml) ≤1.9 9 14 23 1 
 ≥2.0 3 4 7  
Prealpha (%) ≤ 1.80 7 5 12 .14 a 
 > 1.80 5 13 18  
Alpha 1 (%) ≤ 32.60 6 4 10 .14 a 
 > 32.60 6 14 20  
Alpha 2 (%) ≤ 25.25 3 7 10 .69 
 > 25.25 9 11 20  
Prebeta (%) ≤ 12.95 5 5 10 .46 
 > 12.95 7 13 20  
Beta 1 (%) ≤ 19.75 5 5 10 .46 
 > 19.75 7 13 20  
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Chylomicrons (%) ≤ 5.70 4 6 10 1 
 > 5.70 8 12 20  
 
a 
Statistical association P < .20 
Table 4. Results of logistic regression analysis  
 
Factors Dogs with 
symptomatic score 
≥5/total (%) 
OR 95% CI for OR P 
MAP 
≤70 
>70 
 
3/10 (30.0) 
15/20 (75.0) 
 
- 
4.45 
 
 
.31-64.87 
 
 
.27 
SPO2 
≤112 
>112 
 
4/11 (36.4) 
14/19 (73.7) 
 
- 
1.02 
 
 
.07 - 14.00 
 
 
.99 
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Prealpha 
≤2.46 
>2.46 
 
5/12 (41.7) 
13/18 (72.2) 
 
- 
2.16 
 
 
.46 – 14.72 
 
 
.28 
Alpha 1  
≤32.60 
>32.60 
 
4/10 (40.0) 
14/20 (70.0) 
 
- 
1.97 
 
 
.32 - 12.15 
 
 
.46 
Constant  .01  .03 
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